About Us
Eventus Diagnostics, Inc. (EventusDx) is an emerging life sciences company that is developing a new class of accurate and cost-effective immune-based blood tests for the diagnosis of cancer. The company’s first products, the Octava™ Pink and Octava™ Blue tests, are being developed for use with mammography to improve the diagnosis of breast cancer. Read more
Our Technology
Eventus Diagnostics is developing a novel class of rapid, accurate and cost-effective immune-system based blood tests that measure cancer-specific autoantibodies to detect the presence of cancer. These cancer-specific autoantibodies are produced by the immune system in response to the growth of tumors. Our core technology has the unique ability to accurately determine whether an individual has cancer by identifying and measuring combinations of these cancer-specific autoantibodies. Read more
The Mission
The mission of Eventus Diagnostics is to improve the diagnosis and management of cancer by developing and marketing a new class of broadly accessible, non-invasive, rapid, accurate and cost-effective blood tests based on the company’s patented technology that measures cancer-specific autoantibodies to detect whether an individual has cancer. Read more
Breast Cancer
Breast cancer is by far the most common cancer in women worldwide, with an estimated 1.6 million new cases diagnosed in 2010. Its incidence has been increasing in economically developed regions for many years, with the highest incidence of 89.7 cases per 100,000 women reported in Western Europe. About one in eight women in the U.S. (almost 12%) will develop invasive breast cancer over the course of their lifetime. Read more

Comments are closed.